DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "US Giardiasis Market and Competitive Landscape Highlights - 2016" drug pipelines to their offering.
US Giardiasis Market and Competitive Landscape Highlights - 2016, provides comprehensive insights into Giardiasis pipeline products, Giardiasis epidemiology, Giardiasis market valuations and forecast, Giardiasis products sales and competitive landscape in the US.
The research is classified into nine sections - Giardiasis overview including etiology, pathophysiology, and diagnosis, Giardiasis treatment options, Giardiasis pipeline products, Giardiasis market analysis comprising of Giardiasis epidemiology, key products marketed for Giardiasis, market valuations and forecast, products sales and market shares.
- Giardiasis Pipeline: Find out the products in clinical trials for the treatment of Giardiasis by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- Giardiasis Epidemiology: Find out the number of patients diagnosed (prevalence) with Giardiasis in the US
- Giardiasis Products: Identify key products marketed and prescribed for Giardiasis in the US, including trade name, molecule name, and company
- Giardiasis Product Sales: Find out the sales revenues of Giardiasis products, both branded and generics, in the US
- Giardiasis Market Valuations: Find out the market size for Giardiasis products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
- Giardiasis Products Market Share: Find out the market shares for key Giardiasis products in the US
Key Topics Covered:
- Disease Overview
- Giardiasis Treatments
- Giardiasis Pipeline
- US Giardiasis Epidemiology
- Marketed Drugs for Giardiasis in US
- US Giardiasis Market Size
- US Giardiasis Products Sales
- US Giardiasis Market Competitive Landscape
- US Giardiasis Market Forecast
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/zrtr66/us_giardiasis